RBC Global Equity Leaders Fund OCSE:NOVO B Holdings History
RBC Global Equity Leaders Fund's Novo Nordisk AS Holding Summary
As of 2025-03-31, RBC Global Equity Leaders Fund held - shares of Novo Nordisk AS(OCSE:NOVO B), totaling N/A. This investment constitutes 0% of their stock portfolio, and RBC Global Equity Leaders Fund now holds 0% of the outstanding Novo Nordisk AS(OCSE:NOVO B) stock.
The initial trade took place in 2023Q4. And since then RBC Global Equity Leaders Fund has made 2 purchases of OCSE:NOVO B, at an average price of kr688.65, for a total of 2,025.00 shares. In addition, there have been 2 sales at an average price of kr603.11 for 2,025.00 shares. Based on historical transaction data and OCSE:NOVO B's current price of kr414.60, RBC Global Equity Leaders Fund's estimated gain on his OCSE:NOVO B holdings is kr-173,226.04, reflecting a -12.42% gain to date.
RBC Global Equity Leaders Fund OCSE:NOVO B (kr414.60) Holding Chart
RBC Global Equity Leaders Fund OCSE:NOVO B (kr414.60) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price kr-/Share | ||
| Shares Sold | 0 | Average Price kr-/Share | ||
| Current Price kr0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
